PYROTINIB

Clinical trials for PYROTINIB explained in plain language.

Never miss a new study

Get alerted when new PYROTINIB trials appear

Sign up with your email to follow new studies for PYROTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for HER2+ breast cancer: Real-World study tests daily pill pyrotinib

Disease control Not yet recruiting

This study will follow 500 people with HER2-positive advanced breast cancer who are starting treatment with pyrotinib, a daily oral targeted therapy. Researchers want to see how well the drug controls the cancer and what side effects occur in everyday medical practice, not just i…

Matched conditions: PYROTINIB

Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Jun 27, 2026 11:04 UTC

PYROTINIB

Get alerted when new PYROTINIB trials appear

New hope for HER2+ breast cancer: Real-World study tests daily pill pyrotinib